Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5529)
All Articles published online
|
Publishing Process of This Article
|
Dec 20, 2018 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sobhani N, Generali D, Zanconati F, Bortul M, Scaggiante B. Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer. World J Clin Oncol 2018; 9(8): 172-179 [PMID: 30622925 DOI: 10.5306/wjco.v9.i8.172] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v9/i8/172.htm |
| Number | Citing Articles |
| 1 |
Yayun Qian, Yan Yan, Hongmei Lu, Tingting Zhou, Mengying Lv, Chuanci Fang, Jingjing Hou, Wenyuan Li, Xiwen Chen, Hui Sun, Yajuan Li, Zheng Wang, Nan Zhao, Yajuan Gu, Yongling Ding, Yanqing Liu. Celastrus Orbiculatus Extracts Inhibit the Metastasis through Attenuating PI3K/Akt/mTOR Signaling Pathway in Human Gastric Cancer. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(14): 1754 doi: 10.2174/1871520619666190731162722
|
| 2 |
Krisida Cerma, Federico Piacentini, Luca Moscetti, Monica Barbolini, Fabio Canino, Antonio Tornincasa, Federica Caggia, Sara Cerri, Alessia Molinaro, Massimo Dominici, Claudia Omarini. Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges. Biomedicines 2023; 11(1): 109 doi: 10.3390/biomedicines11010109
|
| 3 |
Navid Sobhani, Alberto D’Angelo, Felipe Umpierre Conter, Rachel Morris, Yong Li. Comprehensive Precision Medicine. 2024; : 1 doi: 10.1016/B978-0-12-824010-6.00044-7
|
| 4 |
Azzurra Irelli, Maria Maddalena Sirufo, Carlo D’Ugo, Lia Ginaldi, Massimo De Martinis. Sex and Gender Influences on Cancer Immunotherapy Response. Biomedicines 2020; 8(7): 232 doi: 10.3390/biomedicines8070232
|
| 5 |
Gábor Petővári, Titanilla Dankó, Anna-Mária Tőkés, Enikő Vetlényi, Ildikó Krencz, Regina Raffay, Melinda Hajdu, Dániel Sztankovics, Krisztina Németh, Krisztina Vellai-Takács, András Jeney, Janina Kulka, Anna Sebestyén. In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy. Cancers 2020; 12(9): 2492 doi: 10.3390/cancers12092492
|
| 6 |
Rafael Cuesta, Marina A. Gritsenko, Vladislav A. Petyuk, Anil K. Shukla, Chia-Feng Tsai, Tao Liu, Jason E. McDermott, Marina K. Holz. Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR. Molecular & Cellular Proteomics 2019; 18(8): 1607 doi: 10.1074/mcp.RA119.001506
|
| 7 |
Neslihan Pınar Ozates, Fatma Soğutlu, Ferzan Lermioglu Erciyas, Busra Demir, Cumhur Gunduz, Behrouz Shademan, Cigir Biray Avci. Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer. Life Sciences 2021; 264: 118643 doi: 10.1016/j.lfs.2020.118643
|
| 8 |
Francesco Schettini, Navid Sobhani, Anna Ianza, Tiziana Triulzi, Alfredo Molteni, Maria Chiara Lazzari, Carla Strina, Manuela Milani, Silvia Paola Corona, Marianna Sirico, Ottavia Bernocchi, Fabiola Giudici, Maria Rosaria Cappelletti, Eva Ciruelos, Guy Jerusalem, Sherine Loi, Stephen B. Fox, Daniele Generali. Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study. Breast Cancer Research and Treatment 2020; 184(2): 421 doi: 10.1007/s10549-020-05856-3
|
| 9 |
Busra Demir Cetinkaya, Cigir Biray Avci. Molecular perspective on targeted therapy in breast cancer: a review of current status. Medical Oncology 2022; 39(10) doi: 10.1007/s12032-022-01749-1
|